Glycemic and HbA1c controls of T2DM patients treated with human insulin in China

陆菊明,纪立农,郭晓蕙,谷伟军

DOI: https://doi.org/10.3969/j.issn.1006-6187.2013.09.011

2013-01-01

Abstract:Objective To assess the glycemic and HhA_1c controls of T2DM patients receiving treatment of human insulin regimen in China.Methods From March to June in 2012,T2DM outpatients on the therapy of human insulin.meeting the inclusion criteria.with complete patient medical records,were selected from 314 hospitals across China and filled out the information form.Results Valid data were obtained from 80407 patients,including 44031 males and 36276 females.Patients aged(59.3 ± 10.3) years.The average duration of diabetes was(6.74 ± 4.31)years.The average diabetic course before starting the initial human insulin was(3.75 ± 3.33)years.The 84.6%of patients started insulin therapy due to the poor effect of oral hypoglycemic agents.The average dosage of human insulin was(31.6 + 9.43)U/d.Among patients treated with human insulin,the proportions of patients receiving meal-time insuling plus NPH, meal-time insulin,premixed,and NPH were 3.06%,3.78%,89.8%and 3.4%respectively.The percentage of patients achieving the targets of HbA_1c(<7.0%).FPG(<7.2 mmol/L),2 hPG(≤10 mmol/L) was 27.0%,42.9%,49.8%respectively.Conclusion The glycemic and HbA_1c controls are poor in human insulin treated T2DM patients in China.The proportions of patients receiving premixed human insulin are highest.